Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 2,069 | 2,744 | 3,064 | 5,148 | 7,300 |
| Gross Profit | 2,069 | 2,744 | 3,064 | 5,148 | 7,300 |
| Operating Expenses | 32,276 | 30,246 | 25,588 | 23,690 | 26,703 |
| Operating Income | -30,207 | -27,502 | -22,524 | -18,542 | -19,403 |
| Interest Expense | 2,488 | 0 | 0 | 0 | 0 |
| Other Income | -134 | -1,738 | 3 | -30 | -20 |
| Pre-tax Income | -32,829 | -29,240 | -22,521 | -18,572 | -19,423 |
| Net Income Continuous | -32,829 | -29,240 | -22,521 | -18,572 | -19,423 |
| Net Income | $-32,829 | $-29,240 | $-22,521 | $-18,572 | $-19,423 |
| EPS Basic Total Ops | -1.01 | -0.92 | -0.70 | -0.63 | -0.66 |
| EPS Basic Continuous Ops | -1.01 | -0.92 | -0.70 | -0.63 | -0.66 |
| EPS Diluted Total Ops | -1.01 | -0.92 | -0.70 | -0.63 | -0.66 |
| EPS Diluted Continuous Ops | -1.01 | -0.92 | -0.70 | -0.63 | -0.66 |
| EBITDA(a) | $-30,018 | $-27,311 | $-22,376 | $-18,394 | $-19,244 |